Sharp, part of UDG Healthcare plc, a global provider of contract packaging and clinical supply services, has received Wholesale Distribution Authorization (WDA) and Investigational Medicinal Product (IMP) licensing approvals to support clinical activities from its facility in Heerenveen, Netherlands.   The WDA and IMP licenses mean Sharp can provide EU QP services and distribute IMPs to clinical sites across the continent from a European site.   The existing facility in Heerenveen, which und...